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Chronic high fat feeding restricts 
islet mRNA translation initiation 
independently of ER stress via DNA 
damage and p53 activation
Masayuki Hatanaka1,5,6,7, Emily Anderson-Baucum2,6, Alexander Lakhter1,5,6, Tatsuyoshi 
Kono2,6, Bernhard Maier1,6, Sarah A. Tersey1,5,6, Yukio Tanizawa7, Carmella Evans-
Molina2,3,4,5,6, Raghavendra G. Mirmira1,2,3,4,5,6 & Emily K. Sims  1,5,6
Under conditions of high fat diet (HFD) consumption, glucose dyshomeostasis develops when β-cells 
are unable to adapt to peripheral insulin demands. Few studies have interrogated the molecular 
mechanisms of β-cell dysfunction at the level of mRNA translation under such conditions. We sought 
to address this issue through polyribosome profile analysis of islets from mice fed 16-weeks of 42% 
HFD. HFD-islet analysis revealed clear trends toward global reductions in mRNA translation with a 
significant reduction in the polyribosome/monoribosome ratio for Pdx1 mRNA. Transcriptional and 
translational analyses revealed endoplasmic reticulum stress was not the etiology of our findings. 
HFD-islets demonstrated evidence of oxidative stress and DNA damage, as well as activation of p53. 
Experiments in MIN-6 β-cells revealed that treatment with doxorubicin to directly induce DNA damage 
mimicked our observed effects in islets. Islets from animals treated with pioglitazone concurrently with 
HFD demonstrated a reversal of effects observed from HFD alone. Finally, HFD-islets demonstrated 
reduced expression of multiple ribosome biogenesis genes and the key translation initiation factor 
eIF4E. We propose a heretofore unappreciated effect of chronic HFD on β-cells, wherein continued DNA 
damage owing to persistent oxidative stress results in p53 activation and a resultant inhibition of mRNA 
translation.
Type 2 Diabetes (T2D) is characterized by a combination of peripheral insulin resistance and intrinsic islet β-cell 
dysfunction, culminating in hyperglycemia1. A diet high in fat, such as the typical “Western diet,” can increase 
T2D risk through multiple mechanisms2. Chronically increased serum free fatty acids associated with obesity can 
increase β-cell insulin demand via reductions in insulin sensitivity, but also induce intrinsic β-cell dysfunction via 
endoplasmic reticulum (ER) stress, mitochondrial dysfunction, and oxidative stress3, 4.
To date, much of the analyses of β-cell function in the setting of obesity and insulin resistance have focused 
on investigation of transcriptional regulation and signal transduction pathways5. However, regulation at the level 
of mRNA translation in the β-cell has received less attention, despite a critical role for translational regulation in 
determining cellular protein levels as well as maintaining glucose homeostasis and β-cell function6–10. We have 
previously demonstrated that treatment of β-cells in vitro with the saturated free fatty acid palmitate (to mimic 
the lipotoxic effects of Western diets) had a dichotomous, time-dependent effect on β cell translation11. In the 
short term, palmitate treatment increased insulin production via activation of mammalian target of rapamycin 
complex 1 (mTORC1). By contrast, similar to previous reports of prolonged cytokine incubations, longer-term 
treatment with palmitate in vitro resulted in a translational blockade via activation of ER stress pathways and 
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phosphorylation of eukaryotic translation initiation factor 2α (eIF2α)8, 11. In vivo studies in mice on short-term 
high fat diet (HFD) were consistent with activation of mTORC1 and increased mRNA translation in islets11. 
However, the effects in vivo of long-term exposure to HFD on islet mRNA translation and the underlying cause(s) 
of these effects have heretofore remained unclear.
Here, we investigated the mRNA translational effects of long-term HFD feeding through polyribosome pro-
file (PRP) analysis of islets from C57BL6/J mice fed 16 weeks of HFD. In contrast to our work with short term 
HFD (using HFD with 60% of kcal derived from fat), we chose HFD chow containing 42% of kcal from fat to 
approximate the typical chronic human exposure to a Western diet. We hypothesized that islets from mice on 
chronic HFD would show decreased active β-cell translation due to activation of ER stress pathways. To our sur-
prise, although HFD islets did display a net decrease in translational activity, this effect was not consistent with 
the pattern typically seen in ER stress. Based on a functional pathway analysis from a microarray performed on 
islets from mice treated with HFD, we identified evidence of HFD-induced activation of p53, in turn leading to 
reductions in β-cell translation. Our findings demonstrate that chronic HFD feeding results in a reduction in islet 
mRNA translation initiation that is distinct from ER stress.
Figure 1. Chronic HFD induces global reductions in mRNA translation. Polyribosome profile (PRP) 
analysis was performed on islets from 3–5 mice on regular chow (REG), 42% high fat diet (HFD) or HFD in 
combination with Pioglitazone (HFD + PIO). (a) Representative global profiles are shown. (b) Polyribosome/
monoribosome (P/M) ratios for each treatment group. One way analysis of variance was performed to identify 
between group differences. (c–f) Total input RNA expression for genes related to β cell function and identity, 
including Ins1/2, Pdx1, Gck, and Slc2a, was analyzed. Individual fraction transcript expression for (g) Ins1/2, 
(h) Pdx1, (i) Gck, and (j) Slc2a, was also analyzed. Composite curves representing average values of all animals 
are presented. Average values were significantly different among groups for fraction 7 of the insulin tracing 
and neared significance for fraction 2 of the Pdx1 tracing. (k–n) P/M ratios were calculated for each transcript. 
*p < 0.05, **p < 0.01.
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Results
HFD feeding causes a reduction in islet mRNA translation initiation. Effects of 16 weeks of HFD 
(42% kcal from fat) on metabolic characteristics of this cohort of male C57BL/6 J mice have previously been pub-
lished by our group12. In short, chronic HFD resulted in weight gain, increased visceral fat mass and insulin resist-
ance, increased markers of inflammation, decreased circulating adiponectin, and worsened glucose tolerance 
compared to mice placed on a regular chow diet (REG diet, 17% kcal from fat)12. To assess the effects of chronic 
HFD on islet mRNA translation, we performed PRP analysis on islets isolated from mice in each diet group. PRP 
analysis involves isolating total cellular RNA, followed by use of a sucrose gradient to separate RNA based on the 
nature and number of associated ribosome units9, 13. The representative PRPs from mice on REG diet or HFD in 
Fig. 1a show the association of RNAs with the 40S and 60S ribosomal subunits and monoribosome (80S), which 
collectively indicate initiating or inactively translating RNA species. Conversely, association of RNA species with 
polyribosomes (more than two monoribosomes) generally indicates active translation. The HFD PRP shown in 
Fig. 1a demonstrates the decreased presence of mRNA transcripts in the polyribosome-associated portion of the 
curve, suggesting a net reduction in the rate of mRNA translation initiation (with subsequent “run-off ” of polyr-
ibosomes). Correspondingly, average polyribosome/monoribosome (P/M) ratios in islets of animals on HFD 
tended to be reduced compared to mice on REG diet (Fig. 1b). By contrast, islets from mice on a C57BLKS/J back-
ground, which compensated for HFD treatment with a reduction in food intake, demonstrated no differences in 
global PRPs in response to HFD (Supplemental Fig. 1)12.
Because subtle shifts in global PRPs can reflect large effects on ribosome engagement of specific subsets of 
abundant mRNAs, we evaluated the ribosome engagement of mRNAs encoding insulin (Ins1/2), Pdx1 (Pdx1), 
glucokinase (Gck), and Glut2 (Slc2a2), all known to be important for β-cell function and identity. As shown in 
Fig. 1c–f, the total levels of each of these mRNAs were either unchanged, or in the case of Ins1/2, increased in 
islets from mice fed HFD (compared to REG diet). However, as shown in Fig. 1g–j, HFD feeding consistently led 
to a shift of transcripts towards monosome-associated fractions, suggesting decreased translation of multiple 
crucial β-cell mRNAs. Quantification of P/M ratios for individual mRNAs revealed a significant reduction in P/M 
ratio for Pdx1 transcripts in islets from mice on HFD (Fig. 1l).
Figure 2. HFD-induced reductions in mRNA translation are not caused by ER Stress. (a–c) MIN-6 β cells 
were treated with thapsigargin (Tg) for 4 hours as a positive control for ER stress induction (n = 3 per group). 
(a) Representative global PRPs. For each fraction, transcript expression for (b) Ins1/2 and (c) Ddit3 were 
analyzed. (d) Composite curves representing average Ddit3 transcript expression in PRP fractions from islets 
of mice treated with regular chow (REG), 42% high fat diet (HFD) or HFD in combination with Pioglitazone 
(HFD + PIO). (e) P/M ratios for Ddit3 transcripts in each diet treatment group. (f) Average ATF4 transcript 
expression in PRP fractions from islets of mice in each diet group. (g) P/M ratios for ATF4 transcripts in each 
diet treatment group. (h–j) qRT-PCR analysis of total RNA inputs for genes associated with ER stress signaling, 
including Ddit3, Atf4, and Bip.(k) Representative immunoblot and quantification of phosphorylated eukaryotic 
translation initiation factor 2α (p-eIF2α) expression among diet groups. n = 3–5; *p < 0.05.
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The reduction in translation initiation with HFD feeding is not secondary to ER stress. Next, 
we endeavored to understand if the observed reduction in translation initiation of key β-cell genes was secondary 
to ER stress induced by chronic HFD. As a positive control for robust ER stress, MIN6 β-cells were treated with 
thapsigargin, an inhibitor of the sarco/endoplasmic reticulum Ca2 + ATPase. As shown by the representative 
PRPs in Fig. 2a, thapsigargin induced a translation initiation block, with reduced P/M ratios compared to control 
cells (similar to that observed in islets of HFD fed mice). qRT-PCR performed on individual fractions from the 
PRPs revealed a shift in Ins1/2 transcripts from polyribosome-associated fractions to monosome-associated frac-
tions (Fig. 2b). However, consistent with known effects of ER stress and the unfolded protein response, wherein 
several “privileged” mRNAs escape the general suppression of translation initiation, the mRNA encoding C/EBP 
homologous protein (Chop) (DNA Damage Inducible Transcript 3, Ddit3) demonstrated a shift toward polyri-
bosome engagement with thapsigargin treatment, suggestive of increased translation (Fig. 2c)8, 9. In direct con-
trast to these findings, analysis of islets from mice on chronic HFD failed to demonstrate privileged translation 
of Ddit3 or Activating transcription factor 4 (Atf4) mRNAs (Fig. 2d–g). Instead, transcripts for both Ddit3 and 
Atf4 were shifted toward the monoribosome-associated fractions, with a significant reduction in the P/M ratio 
for Ddit3 in islets from mice treated with HFD. Along these lines, no significant differences between treatment 
groups were found in transcripts isolated from total RNA for multiple genes associated with ER stress signaling 
(Fig. 2h–j). Next, we performed immunoblots to assess for differences in islet phosphorylated eIF2α (p-eIF2α), 
and were unable to detect differences among treatment groups. Although these findings do not preclude acti-
vation of other ER stress pathways, in aggregate, our data suggest that negative effects of chronic HFD on islet 
translation were not consistent with ER Stress-induced repression of translation initiation.
Next, to better model the effects of chronic HFD on β-cell translation, we treated MIN6 β-cells with a mixture 
of palmitate and proinflammatory cytokines (to mimic the chronic lipotoxicity and inflammation expected in 
response to HFD feeding) for 40 hours. PRP analysis revealed a significant reduction in polyribosome-associated 
RNAs, consistent with a net decrease in translation initiation (Fig. 3a). The reduction in polyribosome-associated 
RNAs correlated with a decrease in protein synthesis, as puromycin incorporation was decreased in cells treated 
with palmitate and cytokines (Fig. 3b). However, in contrast to analyses presented in Fig. 2, and consistent with 
our results in islets from HFD treated mice, evaluation of individual mRNAs demonstrated a monoribosome shift 
of Ins1/2, Ddit3, and Atf4 messages (Fig. 3c–e; P/M ratios quantified in Fig. 3f–h).
HFD feeding causes DNA damage, oxidative stress, and activation of p53 signaling. To iden-
tify a molecular etiology for our results, we performed a functional grouping analysis of our previous published 
islet microarray data from these dietary cohorts12. Analysis revealed an upregulation of p53 signaling in islets 
from mice on chronic HFD. A heat map of individual genes identified is displayed in Fig. 4a. To verify this 
Figure 3. Modeling chronic β cell lipotoxicity to mimic in vivo effects of chronic HFD. MIN-6 β cells were 
treated with 40 hours of palmitate + a cytokine mix to mimic chronic lipotoxicity and inflammation (n = 4). 
(a) Representative global PRP tracing. (b) Puromycin incorporation of cells from both treatment groups, 
with quantification of total band intensities. (c–e) PRP analysis of individual transcripts for Ins1/2, Ddit3, and 
Atf4 by fraction.(f–h) Quantification of P/M Ratios for each transcript. *p < 0.05, **p < 0.01, ***p < 0.001, 
****p < 0.0001.
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upregulation, we performed immunofluorescence staining of pancreas tissue for p53. As shown in Fig. 4b,c, p53 
showed increased nuclear staining in islets from mice fed a HFD compared to REG diet, a result consistent with 
p53 activation. Along these lines, immunostaining for the established p53 target gene Cyclin dependent kinase 
inhibitor 1a (Cdkn1a), encoding p21, revealed an upregulation in islets from mice fed a HFD (Fig. 4d)14. qRT-PCR 
from islets from animals in both treatment groups confirmed a significant upregulation in Cdkn1a transcripts in 
islets from HFD-fed mice (Fig. 4e). qRT-PCR was also performed using our in vitro model of cells treated with 
palmitate and proinflammatory cytokines to mimic chronic HFD. A significant increase in Cdkn1a expression 
was also present in cells treated with palmitate and cytokines, confirming that the translation initiation block 
observed in our in vitro model was similarly associated with p53 activation (Fig. 4f). Because our previously pub-
lished data did not demonstrate any evidence of β-cell apoptosis in C57BL/6 J mice on HFD, we also reviewed our 
array data for relative expression of genes that would be expected to be increased by activation of a p53-induced 
apoptotic program12, 15. As shown in Supplemental Figure 2 and consistent with our previous data, relative expres-
sion of these genes was not impacted by HFD.
Activation of p53 is associated with DNA damage16. To identify if the upregulation in p53 signaling occurred 
in association with islet DNA damage, staining for γH2AX, a phosphorylated histone marking double-stranded 
DNA breaks, was performed17. As shown in Fig. 5a, increased γH2AX staining was observed in islets from 
HFD-fed mice, but not in islets of REG diet-fed animals. We suspected that chronic increases in free fatty acids 
and systemic inflammation induced by HFD may have led to increased islet reactive oxygen and nitrogen species 
and oxidative stress, which could explain the observed increase in DNA damage. Staining for 4-hydroxynonenal 
(4-HNE) and nitrotyrosine verified increased oxidative stress in HFD islets (Fig. 5b,c). Lastly, to identify acti-
vation of antioxidant genes as an alternative measure of reactive oxygen species production, qRT-PCR of islets 
from each dietary group revealed a significant upregulation of Gpx1 (encoding Glutathione peroxidase 1), Nfe2l2 
(encoding Nuclear factor E2 Related 2, or Nrf2), and Ppargc1a (encoding peroxisome proliferator-activated recep-
tor gamma coactivator 1α) in HFD-treated animals, consistent with a response to oxidative stress (Fig. 5d–g).
To establish a direct causal link between p53 activation and inhibition of translation initiation, MIN6 β-cells 
were treated with doxorubicin to induce DNA damage and activate p53. Immunoblot analysis performed on 
cells after 12 hours of treatment demonstrated increased levels of phopho-p53 (Ser15), confirming p53 activation 
(Fig. 6a). After 48 hrs of treatment, PRP analysis demonstrated a reduction in the polyribosome-associated RNAs, 
consistent with a net reduction in translation initiation (Fig. 6b).
Figure 4. Evidence of p53 activation in islets from HFD treated mice. (a) Microarray functional grouping 
analysis of islets from each diet group. (n = 4) (b) Representative immunofluorescent staining of p53, insulin, 
and DAPI for islets from each treatment group. (n = 3) (c) Enlarged image of p53 staining in REG and HFD 
treatment groups. (d) Representative immunofluorescent staining of p21, insulin, and DAPI for islets from each 
treatment group. (n = 3) (e) qRT-PCR analysis of total islet RNA for Cdkn1a expression. (n = 4) (f) qRT-PCR 
analysis for Cdkn1a expression in MIN-6 β cells treated with 40 hours of palmitate + a cytokine mix to mimic 
chronic lipotoxicity. *p < 0.05, **p < 0.01.
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PPAR-γ activation reverses the translation inhibitory effect of HFD feeding. We wanted to test 
whether our findings of a HFD-induced translational initiation block could be reversed by reduction of oxida-
tive stress. To this end, as PPAR-γ agonists are known to reduce β-cell oxidative stress, we evaluated mice that 
received HFD compounded with pioglitazone (HFD + PIO)18. Strikingly, PIO treatment reversed the reduction 
in islet translation initiation seen with chronic HFD feeding. This effect was observed in both the PRP analy-
sis (Fig. 1b) and for individual mRNAs evaluated, with a shift in mRNAs towards the polyribosome-associated 
portions of the curve, indistinguishable from animals on REG diet (Figs 1g–n and 2d–g). Islet γH2AX, 4-HNE, 
and nitrotyrosine staining in HFD + PIO fed animals were more comparable to animals on REG diet (Fig. 5a–c). 
Correspondingly, islets from mice on HFD + PIO also had a reversal in p53 signaling on microarray analysis 
(Fig. 4a), reduced nuclear p53 compared to HFD islets (Fig. 4b,c), and p21 levels indistinguishable from mice on 
REG diet (Fig. 4d,e).
Potential Etiologies of p53-related Translation Initiation Blockade. Next we investigated down-
stream targets of p53 activation that could contribute to our observed mRNA translational phenotype. In our 
previous work, we demonstrated that mTORC1 played an important role in regulation of islet translation in 
response to short term, 60% HFD11. p53 signaling has been demonstrated to directly activate Sestrin genes to 
inhibit mTORC1 activity19. Therefore, we performed immunoblots for two major translation promoting targets 
of mTORC1, phosphorylated S6 kinase at T389 (p-S6K) and phosphorylated eIF4E binding protein 1 at T70 
(p-4E-BP1), to evaluate the possibility of reductions in mTORC1 activity in islets from mice on HFD (Fig. 7a)19. 
However, no differences in either p-S6K or p-4E-BP1 were detected. Next, because p53-related inhibition of 
c-myc activity can lead to reductions in the transcription of the important eukaryotic initiation factor eIF4E, we 
performed qRT-PCR for eIF4E transcripts (Fig. 7b)20. Here, we observed a significant reduction in expression 
of eIF4E transcripts in islets from mice on HFD. Lastly, as p53 activation has been associated with reductions 
in genes important for ribosome biogenesis, we quantified relative expression of a panel of ribosome biogen-
esis genes previously shown to be downregulated by p53 induction (BOP1, EBNA1BP2, NOP56, and PA2G4; 
Fig. 7c)21. Relative expression of each of these ribosome biogenesis mRNAs was decreased in islets from mice on 
HFD.
Discussion
The impact of HFD on islet β-cell function is complex, with effects that occur both directly and indirectly (via 
insulin resistance and systemic inflammation). In the short term, elevations in free fatty acids as a result of HFD 
lead to activation of mTORC1, glycerolipid-free fatty acid cycling, and compensatory replication in the β-cell, 
giving rise to enhanced insulin release and increased β-cell mass11, 22–24. Chronic exposure to HFD and elevations 
in free fatty acids are known to have direct effects on β-cell function and survival via islet inflammation, activa-
tion of oxidative and ER stress pathways, and alterations in transcription factor localization and expression4, 25–27. 
However, the effects in vivo of chronic HFD on β-cell mRNA translation have been poorly characterized. In this 
study, we identified a novel relationship between HFD-induced oxidative stress leading to islet DNA damage 
and activation of p53 signaling, and subsequent translational inhibition of key genes relevant to β-cell function 
(Fig. 7). Importantly, our findings were distinct from previously reported effects of prolonged treatment with 
Figure 5. Evidence of DNA damage and oxidative stress in islets from HFD treated mice. (a) Representative 
immunofluorescent staining of γH2AX, insulin, and DAPI for islets from each treatment group. (b) 
Representative immunofluorescent staining of 4-hydroxynonenal (4-HNE), insulin, and DAPI for islets from 
each treatment group. (c) Representative immunofluorescent staining of nitrotyrosine, insulin, and DAPI for 
islets from each treatment group. (d–g) qRT-PCR analysis of total islet RNA for antioxidant genes, including 
Gpx1, SOD1, Nrf2, and Ppargc1α. (n = 3) *p < 0.05, **p < 0.01.
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cytokines alone, which induced a classic phenotype of ER stress-induced translation initiation blockade, with 
increased phosphorylation of eukaryotic translation initiation factor 2α (p-eIF2α) and preferentially increased 
translation of mRNAs encoding Chop and ATF4, as well as preservation of Pdx1 mRNA translation8, 28.
The β-cell is known to be sensitive to excessive ROS accumulation and oxidative stress29. Accordingly, oxi-
dative stress has been proposed as an important contributor to β-cell lipotoxicity, via increased fatty acid β oxi-
dation or NADPH oxidase activity, leading to generation of pathologic levels of reactive oxygen species and 
subsequent β-cell dysfunction and death3, 30, 31. Oxidative stress is an established cause of DNA damage, including 
double-strand DNA breaks, and importantly, both DNA damage and oxidative stress markers are increased in 
islets from T2D patients32, 33. These effects can be mitigated by treatment with antioxidants, or therapies like 
PPAR-γ agonists, which induce antioxidant expression and reduce accumulation of the reactive oxygen and nitro-
gen species associated with oxidative stress3, 5, 18, 30.
p53, a classic tumor suppressor, is a crucial component of the physiologic response to DNA damage, such as 
that induced by oxidative stress16. Activation of p53 and its downstream mediators, such as p21CIP1/WAF1, can result 
in temporary cell cycle arrest, allowing for activity of DNA repair programs, or alternatively, can result in tissue 
dysfunction, senescence, or apoptosis16. Our data suggest that in the context of chronic HFD, p53 contributes 
primarily to islet senescence, rather than activation of apoptotic signaling. Although p53 was first recognized as a 
transcription factor, mounting evidence points to p53 as an important regulator of translation34. Control of trans-
lation can occur through p53-mediated regulation of specific miRNAs, long noncoding RNAs, and RNA binding 
proteins that control translation of specific mRNAs, or via more global effects34, 35. Experiments employing simul-
taneous RNA sequencing of global transcriptomes and polyribosome-associated mRNAs to determine effects on 
transcription and translation have revealed that p53 activation modulates translation but not transcription of a 
large subset of mRNAs, including ribosomal proteins and translation factors21, 35.
Several mechanisms underlying the effect of p53 on global protein synthesis have been identified. 
CAP-dependent initiation of translation is normally regulated by activation of mitogenic pathways, such as mam-
malian target of rapamycin (mTOR)34. Through direct activation of mTOR inhibitors, p53 is able to inhibit mTOR 
signaling resulting in global repression of translation21. p53 binding and inhibition of c-myc results in decreased 
c-myc stimulated transcription of eukaryotic initiation factor eIF4E, which directly recognizes and binds the 
5′ mRNA CAP20. p53 activation also interferes with the interaction of eIF4E and eIF4G, ultimately reducing 
RNA translation initiation36, 37. p53 also affects global translation patterns via inhibition of ribosome biogenesis. 
Transcriptome analysis revealed that p53 activation repressed numerous genes coding for ribosomal proteins or 
involved in regulation of ribosome biogenesis21. In addition, p53 is able to inhibit the recruitment/activity of both 
RNA Polymerase I and III at the rDNA promoters38, 39. Alternatively, p53 has also been identified to target genes 
regulating chemical modifications of ribosomal RNAs, which could affect their functions34. Our data point to 
reductions in islet transcription of eIF4E as well as several genes involved in ribosome biogenesis in association 
with activation of p53 signaling. Future work will further elucidate these relationships, as well as other down-
stream effectors of p53 activation within the islet.
Several other reports have explored the role of p53 in the β-cell. Increased pancreatic radiation doses incurred 
for cancer treatment in childhood are associated with increased development of T2D in adulthood, suggesting 
a potential effect of radiation-induced DNA damage40. Intriguingly, evidence of DNA damage and p53 activity, 
including increased p21 expression, has previously been demonstrated in islets from db/db mice and humans with 
T2D41–43. Mice overexpressing Δ40p53, an isoform of p53 that stabilizes the full length protein, demonstrated 
increased p21 expression, reduced cyclin D2 and Pdx-1 expression, and reduced β-cell proliferation and β-cell 
mass, eventually leading to hypoinsulinism and frank diabetes44. Genetic knockout of β-cell p53 was able to pre-
vent oxidative stress-induced β-cell apoptosis in a mouse model of congenital hyperinsulinism41. Interestingly, 
genome-wide association studies have identified an association between a polymorphism in p53 codon 72 and 
T2D susceptibility45, 46.
Because of technical limitations associated with analyses of large numbers of mice, our data were obtained 
from several time-points occurring over a 4-week period (12 weeks, 14 weeks, and 16 weeks), with global effects 
on PRPs observed after 16 weeks of diet. Not all studies were able to be performed at every time-point, and 
Figure 6. β cell DNA damage to induce p53 activation leads to global reductions in mRNA translation. 
MIN-6 cells were treated with doxorubicin to directly induce DNA damage. (a) Protein levels of both total and 
phospho-p53 were assayed after 12 hours of treatment with doxorubicin. (b) Global PRP analysis after 48 hours 
of doxorubicin treatment.
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effects of chronic HFD and ROS accumulation may have continued to evolve over this time period. However, we 
observed evidence of p53 activation at each time-point, suggesting that activation of this signaling pathway plays 
an important role in the islet response to HFD that persists over time. Along these lines, our observation that the 
translation initiation blockade was inconsistent with the classic translation blockade associated with ER stress 
may be a reflection of an evolving chronic response to activation of these pathways.
HFD feeding in our study resulted in evidence of a blockade in translation initiation, with subtle shifts towards 
the monoribosome-associated portion of the PRP curve for most transcripts evaluated. These findings are in line 
with other mild β-cell effects found in this cohort, including the absence of defects in GSIS or of β-cell death12. 
In part, these findings likely reflect our choice of a more moderate high fat diet (42% of kcal from fat), in contrast 
to other studies utilizing diets with 60% of kcal from fat, in which abnormalities in GSIS were identified47, 48. Our 
own previously reported observations of short-term effects of HFD were performed using a 60% HFD11. It is pos-
sible that we may have observed more pronounced or different effects with a higher percentage HFD. However, 
our decision to treat with Western diet in this work was made in an attempt to mimic chronic HFD and obesity 
encountered by humans, with resulting findings physiologically relevant to human diabetes. Furthermore, subtle 
shifts in the global PRP reflect substantial changes in the translation of numerous individual transcripts, as we 
observed by demonstrating similar patterns in translation of multiple β-cell function and ER stress transcripts. 
Certainly, even small changes in translation of key β-cell function and survival genes, over years of accumulated 
DNA damage, could collectively lead to larger scale effects on β-cell function. Taken together, our data provide 
Figure 7. Mechanisms of HFD effects on β cell mRNA translation. (a) Immunoblots for phosphorylated S6 
kinase at T389 (p-S6K) and phosphorylated eIF4E binding protein 1 at T70 (p-4E-BP1) in islets from mice 
on regular diet and HFD. (b) q-PCR evaluating relative expression of eIF4E transcripts. (c) q-PCR evaluating 
relative expression of ribosome biogenesis genes BOP1, EBNA1BP, NOP56, and PA2G4. n = 3–4; *p < 0.05, 
**p < 0.01, ***p < 0.001. (d) Proposed mechanisms of HFD-induced reductions in β cell translation.
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evidence that chronic HFD feeding results in a translational block in islets that is referable to activation of p53 and 
not an induction in classical ER stress.
Methods
Animals, Islets, and Cell Lines. As previously described, male C57BL/6 J and C57BLKS/J mice were 
obtained from Jackson Laboratories (Bar Harbor, ME), and maintained under protocols approved by the Indiana 
University School of Medicine Institutional Animal Care and Use Committee in accordance with the Association 
for Assessment and Accreditation of Laboratory Animal Care guidelines. Beginning at 8 weeks of age, for 12–16 
weeks, animals were fed either regular chow containing 17% calories from fat (REG diet), high fat diet containing 
42% calories from fat (HFD), or high fat diet compounded by Harlan-Teklad Global with 140 mg/kg of pioglita-
zone (HFD + PIO), calculated to provide a dose of 20 mg/kg/day of pioglitazone12.
Mouse islets were isolated from collagenase-perfused pancreata and cultured in RPMI 1640 medium and 
allowed to recover overnight prior to experimentation as previously described49. For PRP experiments, islets were 
transferred into cold RPMI medium containing 5 mM glucose after isolation and used immediately. The MIN6 
mouse insulinoma cell line was maintained in culture conditions as described11. MIN6 cells were treated with 
1 μM thapsigargin, 1 μM doxorubicin, or 0.5 mM palmitate (Sigma-Aldrich) in combination with a cytokine mix 
of 5 ng/ml IL-1β, 10 ng/ml TNF-α, and 100 ng/ml IFN-γ for indicated time periods. For all cell line data, results 
represent the means of at least three independent experiments.
Polyribosome Profile (PRP) Experiments. PRP experiments with MIN6 cells and islets were performed 
as previously described8. Briefly, a portion of the cell lysate was preserved as the input sample to determine total 
mRNA levels. Lysates were passed through a 10–50% sucrose gradient and fractionated using a BioComp pis-
ton gradient fractionator. RNA absorbance at 254 nm was recorded using an in-line UV monitor and fractions 
were collected. Monoribosome-associated RNA was collected from fractions 1 to 5 and polyribosome-associated 
RNA was collected from fractions 6–10. Global polyribosome-to-monoribosome (P/M) ratios were quantitated 
by calculating the area under the curve corresponding to the polyribosome peaks (more than two ribosomes) 
divided by the area under the curve for the monoribosome (80S) peak. Total RNA from each fraction was reverse 
transcribed and subjected to qRT-PCR. P/M Ratios for each mRNA were quantitated by calculating the area 
under the curve for fractions 7–9, divided by the area under the curve for fractions 2–3. PRP studies on islets were 
performed after 16 weeks of treatment.
Immunoblot analysis. Whole-cell extracts from cell lines and islet lysates were prepared and subjected to 
immunoblot analysis as described previously11. For immunoblotting of puromycin incorporation into protein, 
puromycin was added to the culture medium at 1 ug/mL during the final 15 minutes of incubation. Cells were 
then washed twice with cold PBS and lysed. Immunoblot analyses were performed after separation of protein 
extracts on a 4% to 20% gradient SDS-polyacrylamide gel and were visualized using fluorescently labeled pri-
mary antibody to puromycin (mouse anti-puromycin, 1:1000 concentration, Kerafast, Catalog number EQ0001), 
p-4EBP1 (rabbit anti-p-4EBP1, 1:1000, Cell Signaling Technology, number 9455), p-p70 S6K (Thr389) (rabbit 
anti-p-p70S6K, 1:1000, Cell Signaling Technology, number 2708), p-eIF2α (rabbit anti-p-eIF2 α, 1:1000, Cell 
Signaling Technology, number 9721), and secondary antibodies (Li-Cor Biosciences) and quantified using a 
Li-Cor Odyssey scanner and Image J 1.38x50.
Quantitative real-time RT-PCR (qRT-PCR). Total RNA from MIN6 cells and islets was recovered using 
an RNeasy kit (Qiagen), reverse transcribed, and subjected to qRT-PCR using SyBR Green based methodol-
ogy11. Data for input RNA were normalized to TATA box binding protein (Tbp) or Glyceraldehyde-3-Phosphate 
Dehydrogenase (GAPDH) message. Primer sequences were previously described for Insulin, Pdx1, Gck, Slc2a2, 
Ddit3, Atf4, Tbp, Gpx1, Nrf2, and Ppargc1a8, 51–54. Other primer sequences used were as follows: Block of prolifer-
ation 1 (BOP1): forward: 5′-GGCCCAACATGAATATGAAG-3′, reverse: 5′-TTGTAGATACGTTTGCCATC-3′; 
EBNA1 Binding Protein 2 (EBNA1BP2): forward: 5′-ATAAGCTGGATTTCCTGGAG-3′ , reverse: 
5′-ATTAGGCCCTTTACTCATCTG-3′; NOP56: forward: 5′-CCAGAGGAGTGTGAGGAGGTA-3′, 
reverse: 5′-GAGACAGGTGGGTCTTCCATTCC-3′; Proliferation-Associated 2G4 PA2G4: forward: 
5′-GAAGGAGGGTGAATTTGTTG-3′, reverse: 5′-ATCTTGAACCTCCATCTCAG-3′. For Cdkn1a and gapdh, 
Taqman gene expression master mix reagents and gene expression assay probes were used (Applied Biosystems). 
Islets used for both immunoblot and PCR were isolated after 16 weeks of diet.
Microarray analysis. After 12 weeks of diet, Agilent Whole Mouse Genome Oligo Microarray was per-
formed on islets from 4 mice per treatment group by MACs Molecular; description and full results have previ-
ously been reported12. Functional grouping and annotation analysis of these results were performed by Miltenyi 
Bioinformatics.
Immunofluorescence. After 14 weeks of diet, pancreata from 3 mice per treatment group were fixed by 
cardiac perfusion with 4% paraformaldehyde, paraffin embedded, and sectioned longitudinally at 5 μm intervals. 
Immunofluorescence experiments were performed on 2 sections per animal for insulin (guinea pig anti-porcine, 
Abcam, 1:250, AB7842), 4-HNE (rabbit anti-4HNE, Abcam 1:1000, AB66155), nitrotyrosine (rabbit anti-mouse, 
Millipore, 1:250, AB5411), p21 (rabbit anti-mouse, Santa Cruz, 1:250, sc397), p53 (rabbit anti-mouse, Santa 
Cruz, 1:250, sc6243), γH2AX pSer140 (mouse anti-mouse; Novus Biologicals, 1:150, NB100-74435), and nuclei 
(diamidino-2-phylindole- DAPI). Secondary antibodies were goat anti-rabbit antibody conjugated to Alexa 
Fluor 488 (Molecular Probes, 1:500) and goat anti-guinea pig antibody conjugated to Alexa Fluor 555 (Molecular 
Probes, 1:500). An SM 700 (Zeiss, Thornwood, NY) confocal equipped with an Orca ER charge-coupled device 
camera (Hamamatsu Photonics, Hamamatsu City, Japan) was used to acquire digital images.
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Statistics. Statistical analyses were performed using GraphPad Prism (GraphPad Software, La Jolla, 
California). Student’s t-tests were used for comparison between treatment and control groups. One-way ANOVA 
with Dunnet’s post-test, or for nonparametric distributions, Kruskal-Wallis test with Dunn’s test for multiple 
comparisons, were utilized when comparing >2 groups. For all analyses, a p value of ≤0.05 was considered 
significant.
Data availability statement. The datasets generated during the current study are available from the corre-
sponding author on reasonable request. The dataset from the microarray analyzed in the current study has been 
deposited in NCBI’s Gene Expression Omnibus and is accessible through GEO Series accession no. GSE51055 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi? acc=GSE51055).
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